B. Riley Securities Downgrades AlerisLife to Neutral, Lowers Price Target to $1.5
B. Riley Securities downgrades AlerisLife (NASDAQ:ALR) from Buy to Neutral and lowers the price target from $5 to $1.5.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 211 companies set new 52-week lows.
Earnings Scheduled For May 3, 2022
Companies Reporting Before The Bell
• Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
AlerisLife Q4 EPS $(0.34) Down From $0.09 YoY
AlerisLife (NASDAQ:ALR) reported quarterly losses of $(0.34) per share. This is a 477.78 percent decrease over earnings of $0.09 per share from the same period last year.